JP2013523623A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523623A5
JP2013523623A5 JP2013500543A JP2013500543A JP2013523623A5 JP 2013523623 A5 JP2013523623 A5 JP 2013523623A5 JP 2013500543 A JP2013500543 A JP 2013500543A JP 2013500543 A JP2013500543 A JP 2013500543A JP 2013523623 A5 JP2013523623 A5 JP 2013523623A5
Authority
JP
Japan
Prior art keywords
treatment
compound
disease
composition
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013500543A
Other languages
English (en)
Japanese (ja)
Other versions
JP5575324B2 (ja
JP2013523623A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/ES2010/070156 external-priority patent/WO2011117429A1/es
Publication of JP2013523623A publication Critical patent/JP2013523623A/ja
Publication of JP2013523623A5 publication Critical patent/JP2013523623A5/ja
Application granted granted Critical
Publication of JP5575324B2 publication Critical patent/JP5575324B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013500543A 2010-03-26 2010-03-26 カンナビノイド・キノン誘導体 Expired - Fee Related JP5575324B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2010/070156 WO2011117429A1 (es) 2010-03-26 2010-03-26 Derivados quinona de cannabinoides

Publications (3)

Publication Number Publication Date
JP2013523623A JP2013523623A (ja) 2013-06-17
JP2013523623A5 true JP2013523623A5 (enExample) 2013-09-26
JP5575324B2 JP5575324B2 (ja) 2014-08-20

Family

ID=43087054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013500543A Expired - Fee Related JP5575324B2 (ja) 2010-03-26 2010-03-26 カンナビノイド・キノン誘導体

Country Status (5)

Country Link
US (1) US8772349B2 (enExample)
EP (1) EP2551255B1 (enExample)
JP (1) JP5575324B2 (enExample)
ES (1) ES2657940T3 (enExample)
WO (1) WO2011117429A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014013117A1 (es) * 2012-07-18 2014-01-23 Consejo Superior De Investigaciones Científicas (Csic) Cromenopirazoldionas como derivados cannabinoides de quinonas con actividad antitumoral
ES2894760T3 (es) * 2014-02-27 2022-02-15 Emerald Health Pharmaceuticals Inc Nuevos derivados de cannabigerol
ES2548789B1 (es) * 2014-03-18 2016-08-08 Consejo Superior De Investigaciones Científicas (Csic) Nuevas cromenoquinonas moduladoras de receptores cannabinoidescb2 con actividad antitumoral
EP3131874B1 (en) 2014-04-16 2018-07-25 Emerald Health Pharmaceuticals Inc. Novel cannabidiol quinone derivatives
CN106860438B (zh) * 2017-01-23 2020-05-22 延边大学 苯醌衍生物在制备抗肝纤维化药物中的应用
IL269623B2 (en) * 2017-03-29 2025-05-01 Emerald Health Pharmaceuticals Inc Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activity
JP2022511952A (ja) * 2018-12-11 2022-02-01 エメラルド ヘルス ファーマシュウティカルズ インコーポレイテッド カンナビゲロールキノン酸およびその塩
EP3937925A1 (en) * 2019-03-12 2022-01-19 EPM (IP), Inc. Cannabinoid acid ester compositions and uses thereof
IL293476A (en) * 2019-12-05 2022-08-01 B G Negev Technologies And Applications Ltd At Ben Gurion Univ Biodegradable polymeric preparations, preparation methods and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03003733A (es) * 2000-10-26 2004-10-15 Fournier Lab Ireland Ltd Combinacion de fenofibrato y coenzima q10 para el tratamiento de la disfuncion endotelial.
IL159892A0 (en) 2004-01-15 2004-06-20 Yissum Res Dev Co Use of quinonoid derivatives of cannabinoids in the treatment of malignancies
US20100152238A1 (en) * 2007-03-05 2010-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel quinonoid derivatives of cannabinoids and their use in the treatment of malignancies
GB2456183A (en) * 2008-01-04 2009-07-08 Gw Pharma Ltd Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament

Similar Documents

Publication Publication Date Title
AR122395A2 (es) Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina
JP2013525444A5 (enExample)
JP2010001302A5 (enExample)
JP2015145426A5 (enExample)
EA201071298A1 (ru) Соединение 3-аминокарбазола, фармацевтическая композиция, его содержащая, и способ их получения
JP2020519654A5 (enExample)
JP2014510110A5 (enExample)
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
JP2018520205A5 (enExample)
EA201690521A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
WO2010022177A3 (en) Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
JP2012504133A5 (enExample)
JP2011518833A5 (enExample)
JP2013522326A5 (enExample)
JP2010506953A5 (enExample)
EP2771307A4 (en) PROCESS FOR THE PRODUCTION OF ACRYLATES FROM EPOXIDES
JP2015517579A5 (enExample)
BR112014005389A8 (pt) Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal
JP2013522367A5 (enExample)
WO2016105118A3 (ko) Gpr120 효능제로서의 바이아릴 유도체
JP2016540749A5 (enExample)
JP2018521121A5 (enExample)
EP2390014A4 (en) PROCESS FOR OBTAINING AND PRODUCING ETHANOL AND OIL
WO2014059232A3 (en) Substituted spiropiperidinyl compounds useful as gpr120 agonists
JP2011046708A5 (enExample)